Wednesday, June 10, 2026

pharma

Bial - Portela

Bial - Portela patent portfolio — 21 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

TROFA, PT HQ
EMA registrant Type
Company details
Status
Public
HQ
TROFA, PT
Programs
0
Drugs
0
Patents
21
Intelligence · Patents

Bial - Portela patents

21 pharmaceutical patents indexed for Bial - Portela. 0 expire within 24 months.

Bial - Portela has 21 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. WO 2022081033

    OPICAPONE ET LÉVODOPA POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON

    Expires Wed Apr 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. WO 2022025781

    DISPERSION SOLIDE D'OPICAPONE

    Expires Wed Jan 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. WO 2021182981

    OPICAPONE MICRONISÉE

    Expires Wed Sep 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. WO 2020246903

    INHIBITEURS DE DOPAMINE-B-HYDROXYLASE

    Expires Wed Dec 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. AU 2018379646

    Dopamine-B-hydroxylase inhibitors

    Expires Wed Jun 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. BR PI0923819

    compostos farmacêuticos

    Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. EP 3515433

    DIE BLUT-HIRN-SCHRANKE PASSIERENDE DOPAMIN-B-HYDROXYLASE-INHIBITOREN

    Expires Tue Jul 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 2019008774

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THE SAME

    Expires Wed Jan 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. PT 2114927

    PROCESS FOR THE PREPARATION OF (R)-5-(2-AMINOETHYL)-1-(6,8-DIFLUOROCHROMAN-3-YL)-1,3-DIHYDROIMIDAZOLE-2-THIONE

    Expires Thu Nov 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. PT 2121138

    THERAPEUTICAL USES OF ESLICARBAZEPINE

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. PT 2214636

    ORAL DOSAGE FORMS COMPRISING LICARBAZEPINE ACETATE

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. PT 2481410

    NITROCATECHOL DERIVATES AS COMT INHIBITORS ADMINISTERED WITH A SPECIFIC DOSAGE REGIME

    Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 2015359783

    PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

    Expires Wed Dec 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. PT 2303855

    CATALYTIC PROCESS FOR ASYMMETRIC HYDROGENATION

    Expires Tue Mar 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. WO 2015016729

    COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. WO 2015016728

    COMPOSÉS D'URÉE ET LEUR UTILISATION COMME INHIBITEURS DE L'ENZYME FAAH

    Expires Wed Jan 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. EP 2791134

    CHEMISCHE VERBINDUNG ALS ZWISCHENPRODUKT ZUR HERSTELLUNG EINES CATECHOL-O-METHYLTRANSFERASE-INHIBITORS

    Expires Tue Oct 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. WO 2014163518

    TRAITEMENTS UTILISANT L'ESLICARBAZÉPINE ET L'ACÉTATE D'ESLICARBAZÉPINE

    Expires Wed Oct 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. EP 2747770

    BEHANDLUNGEN MIT ESLICARBAZEPINACETAT ODER ESLICARBAZEPIN

    Expires Tue Jun 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. CA 2890920

    DERIVES DE 1,3-DIHYDROIMIDAZOLE-2-THIONE UTILISABLES DANS LE TRAITEMENT DE L'HYPERTENSION ARTERIELLE PULMONAIRE ET DES LESIONS PULMONAIRES

    Expires Wed May 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. MX 2013007491

    GRANULATES COMPRISING ESLICARBAZEPINE ACETATE.

    Expires Wed Jul 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Bial - Portela have?

21 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Bial - Portela patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.